Anakinra, a recombinant human IL-1 receptor antagonist, in clinical practice. Outcome in 60 patients with severe rheumatoid arthritis
Botsios, C., Sfriso, P., Furlan, A., Ostuni, P., Biscaro, M., Fiocco, U., Todesco, S., Punzi, L.Volume:
59
Journal:
Reumatismo
DOI:
10.4081/reumatismo.2007.32
Date:
September, 2011
File:
PDF, 130 KB
2011